TrialThe American journal of gastroenterology2012
A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation.
Satish Rao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
161 papers cite itlatest 60 shown
this paperpooled ittrialcites it